Cell · 2025
A 3D in vitro model for studying human implantation and implantation failure.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Qian, Yuan Yang, Zhao Wentao, Li Yuanjun, Shi Juanzi, Xiu Yu, Han Mi, Han Yan, Zhang Junmei, Cheng Shuhan, Qi Xin, Sun Xizhuang, Jia Tan, Xing Jiaqi, Deng Siwei, Yan Xiaodi, Oura Seiya, Li Hongfei, Sun Ying, Yuan Huiyao, Ma Xiaohong, Xin Miaomiao, Zhao Jianchao, Zhu Xili, Wang Cong, Wang Qin, Lin Ge, Yang Xiaokui, Wei Yulei, Wu Jun, Wang Hongmei, Yu Leqian
Аннотация
A better understanding of human implantation is essential for improving assisted reproduction outcomes and addressing recurrent implantation failure (RIF). However, ethical constraints and limited access to human embryos make direct studies challenging. To overcome this, we developed a 3D in-chip implantation model using human blastoids or blastocysts co-cultured with a bioengineered human endometrial tissue, termed endometrioid. This system successfully recapitulates key events of human implantation and early post-implantation development. Importantly, when modeling implantation using samples derived from RIF patients, we observed significantly reduced blastoid implantation capability compared with endometrioids from fertile controls. Furthermore, a targeted screen of U.S. Food and Drug Administration (FDA)-approved compounds identified candidates that markedly enhanced implantation efficiency in RIF-derived endometrioids. Together, this 3D platform enables mechanistic investigation of human implantation and implantation failure and offers a scalable approach to evaluate therapeutic strategies for improving embryo-endometrium interaction in a clinical setting.